• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[基于指南的质量指标的制定:从S3指南作者角度对障碍和促进因素的定性研究]

[Development of guideline-based quality indicators: a qualitative study on barriers and facilitating factors from the perspective of S3-guideline authors].

作者信息

Arnold Katrin, Breuing Jessica, Becker Monika, Nothacker Monika, Neugebauer Edmund, Schmitt Jochen, Deckert Stefanie

机构信息

Zentrum für Evidenzbasierte Gesundheitsversorgung (ZEGV), Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, 01307, Dresden, Deutschland.

IFOM - Institut für Forschung in der Operativen Medizin, Department für Humanmedizin Universität Witten/Herdecke, 51109, Köln, Deutschland.

出版信息

Z Evid Fortbild Qual Gesundhwes. 2019 Nov;147-148:34-44. doi: 10.1016/j.zefq.2019.09.001. Epub 2019 Nov 13.

DOI:10.1016/j.zefq.2019.09.001
PMID:31732386
Abstract

BACKGROUND

Evidence-based and formally consensus-based clinical practice guidelines (S3-CPGs) are a valuable source for the development of quality indicators (QIs) in Germany. While deriving QIs from guideline recommendations is a mandatory part of the development of S3-CPGs within the National Program for Disease Management Guidelines (DMGP) and the German Guideline Program in Oncology (GGPO), there is no such obligation in the guideline program of the Association of the Scientific Medical Societies in Germany (AWMF) (MS program). Despite that, several S3-CPGs in the MS program have been published with QIs in the last years while some DMGP and one GGPO S3 guidelines have failed to meet this requirement. From the perspective of the guideline authors of all three mentioned programs, the present qualitative study examined why S3-CPGs do or do not contain QIs and explored the factors perceived by authors as either facilitating or hampering in the QI development process.

METHODS

Semi-structured interviews were conducted with authors of 22 S3-CPGs, 11 of which represented guidelines containing QIs and 11 of which represented guidelines without QIs. Authors of guidelines containing QIs (n=11) were asked about the perceived decisive reasons for formulating QIs and about facilitators and barriers during the QI development process. Authors of guidelines without QIs (n=11) gave reasons for not formulating QIs. Interviews were analyzed using structuring qualitative content analysis.

RESULTS

Within the MS program, not formulating QIs was mainly attributed to the lack of a mandatory requirement and to insufficient funding of guideline projects. Amongst DMGP authors, a low priority of QI development prevailed, which was, for example, due to already existing QIs or to their lacking implementation. In the GGPO guideline examined, not formulating QIs was due to the guideline topic (prevention) - for this topic, there was a lack of suitable evidence and data sources. If QIs were developed, the most important facilitating factor in the development process, across all programs, was the methodological support provided by the guideline program. Important hampering factors included the additional time required for QI development and concerns regarding the implementation of many potential QIs, especially due to a lack of data availability.

DISCUSSION

For regular development of QIs within S3-CPG projects, the incorporation of such a requirement in the guideline program is a necessary, but not a sufficient, condition. Other pivotal factors include systematic methodological support, adequate financial and staff resources and the perceived meaningfulness and relevance of guideline-based QI development, measured in terms of the actual implementation of already existing QIs.

CONCLUSION

The study reveals starting points for measures to strengthen the consideration of QI development in German S3-CPG projects, especially within the MS program. Without substantial structural changes, especially of the resources of guideline groups, and without an overall concept covering the entire process from QI development to QI implementation, guideline-based QI development will remain heavily dependent on the (self-)motivation of guideline groups.

摘要

背景

循证且基于正式共识的临床实践指南(S3 - CPGs)是德国制定质量指标(QIs)的宝贵来源。虽然从指南建议中推导质量指标是国家疾病管理指南计划(DMGP)和德国肿瘤学指南计划(GGPO)中S3 - CPGs制定的强制性部分,但在德国科学医学协会联合会(AWMF)的指南计划(MS计划)中并无此义务。尽管如此,在过去几年中,MS计划中的一些S3 - CPGs已发布了质量指标,而一些DMGP和一个GGPO S3指南未能满足这一要求。从上述三个计划的指南作者的角度来看,本定性研究探讨了S3 - CPGs为何包含或不包含质量指标,并探究了作者认为在质量指标制定过程中促进或阻碍的因素。

方法

对22份S3 - CPGs的作者进行了半结构化访谈,其中11份代表包含质量指标的指南,11份代表不包含质量指标的指南。包含质量指标的指南的作者(n = 11)被问及制定质量指标的决定性原因以及质量指标制定过程中的促进因素和障碍。不包含质量指标的指南的作者(n = 11)给出了不制定质量指标的原因。采用结构化定性内容分析法对访谈进行分析。

结果

在MS计划中,不制定质量指标主要归因于缺乏强制性要求以及指南项目资金不足。在DMGP作者中,质量指标开发的优先级较低,例如,这是由于已有质量指标或缺乏实施所致。在所研究的GGPO指南中,不制定质量指标是由于指南主题(预防)——对于该主题,缺乏合适的证据和数据源。如果制定了质量指标,在所有计划的制定过程中,最重要的促进因素是指南计划提供的方法学支持。重要的阻碍因素包括质量指标开发所需的额外时间以及对许多潜在质量指标实施的担忧,特别是由于缺乏数据可用性。

讨论

为了在S3 - CPG项目中定期开展质量指标开发,在指南计划中纳入这样的要求是必要条件,但并非充分条件。其他关键因素包括系统的方法学支持、充足的资金和人员资源,以及基于指南的质量指标开发在实际实施现有质量指标方面的感知意义和相关性。

结论

该研究揭示了加强德国S3 - CPG项目中质量指标开发考量的措施的起点,特别是在MS计划中。如果没有实质性的结构变化,特别是指南小组资源的变化,以及没有涵盖从质量指标开发到质量指标实施的整个过程的总体概念,基于指南的质量指标开发将严重依赖于指南小组的(自我)积极性。

相似文献

1
[Development of guideline-based quality indicators: a qualitative study on barriers and facilitating factors from the perspective of S3-guideline authors].[基于指南的质量指标的制定:从S3指南作者角度对障碍和促进因素的定性研究]
Z Evid Fortbild Qual Gesundhwes. 2019 Nov;147-148:34-44. doi: 10.1016/j.zefq.2019.09.001. Epub 2019 Nov 13.
2
[(How) Are quality indicators for measuring and appraising the quality of healthcare derived from evidence-based clinical practice guidelines? A review].[(如何)从循证临床实践指南中得出用于衡量和评估医疗质量的质量指标?一项综述]
Z Evid Fortbild Qual Gesundhwes. 2019 Nov;147-148:45-57. doi: 10.1016/j.zefq.2019.09.002. Epub 2019 Nov 10.
3
Guideline-based quality indicators-a systematic comparison of German and international clinical practice guidelines: protocol for a systematic review.基于指南的质量指标——德国与国际临床实践指南的系统比较:系统评价方案。
Syst Rev. 2018 Jan 12;7(1):5. doi: 10.1186/s13643-017-0669-2.
4
[Methodological Standard for the Development of Quality Indicators within Clinical Practice Guidelines - Results of a structured consensus process].[临床实践指南中质量指标制定的方法标准——结构化共识过程的结果]
Z Evid Fortbild Qual Gesundhwes. 2021 Feb;160:21-33. doi: 10.1016/j.zefq.2020.11.008. Epub 2021 Jan 20.
5
Guideline-based quality indicators-a systematic comparison of German and international clinical practice guidelines.基于指南的质量指标——德国与国际临床实践指南的系统比较。
Implement Sci. 2019 Jul 9;14(1):71. doi: 10.1186/s13012-019-0918-y.
6
Development and Update of Guideline-based Quality Indicators in Lung Cancer.基于指南的肺癌质量指标的制定与更新。
Pneumologie. 2024 Apr;78(4):250-261. doi: 10.1055/a-2204-4879. Epub 2023 Dec 11.
7
[Measuring quality in the German Guideline Programme in Oncology (GGPO)—methodology and implementation].[德国肿瘤学指南计划(GGPO)中的质量评估——方法与实施]
Z Evid Fortbild Qual Gesundhwes. 2014;108(8-9):470-80. doi: 10.1016/j.zefq.2014.09.021. Epub 2014 Oct 30.
8
International experiences in the development and implementation of guideline-based quality indicators: a qualitative study.国际上基于指南的质量指标的制定和实施经验:一项定性研究。
BMJ Open. 2021 Jan 19;11(1):e039770. doi: 10.1136/bmjopen-2020-039770.
9
Guideline-Based Quality Indicators for Kidney and Bladder Cancer in Germany: Development and Implementation.德国基于指南的肾脏和膀胱癌质量指标:制定与实施。
Urol Int. 2022;106(4):360-367. doi: 10.1159/000517893. Epub 2021 Aug 12.
10
[The Quality indicator project of the German college of general practice and family medicine (DEGAM): development of indicators based on the guidelines dementia, neck pain and sore throat].[德国全科与家庭医学学院(DEGAM)的质量指标项目:基于痴呆、颈部疼痛和喉咙痛指南制定指标]
Z Evid Fortbild Qual Gesundhwes. 2013;107(1):74-86. doi: 10.1016/j.zefq.2012.11.016. Epub 2012 Dec 7.

引用本文的文献

1
International experiences in the development and implementation of guideline-based quality indicators: a qualitative study.国际上基于指南的质量指标的制定和实施经验:一项定性研究。
BMJ Open. 2021 Jan 19;11(1):e039770. doi: 10.1136/bmjopen-2020-039770.